| Business Summary |
| A specialty pharmaceutical company that is utilizing licensed and owned proprietary drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, significant new formulations of proven therapeutics. |
| General Information |
801 Corporate Center Drive
Suite 210
Raleigh, NC 27607
|
| www.bdsinternational.com |
| Industry : Drugs |
| Sector: Health Care |
| Employees: 20 |
| CEO: Dr. Mark A. Sirgo, Pharm |
| Short Interest |
| Current Month (Mil) |
1.10 |
| Previous Month (Mil) |
1.09 |
| Short Interest Ratio (Days) |
7.20 |
| Management Effectiveness |
| Return on Equity |
n.a. |
| Return on Assets |
-70.60 |
| Return on Investments |
72.60 |
| Profitability |
| Gross Margin |
n.a. |
| EBIT Margin |
n.a. |
| Profit Margin |
0.00 |
Connect with TheStreet